Ghent University-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

    ESMO Open, Vol. 7, Núm. 5

2016

  1. Factors Associated with Early Mortality in Patients Treated with Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 3, pp. 612-620

2015

  1. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

    International Journal of Radiation Oncology Biology Physics, Vol. 91, Núm. 1, pp. 133-139

2013

  1. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: An individual patient data meta-analysis

    International Journal of Radiation Oncology Biology Physics, Vol. 87, Núm. 4, pp. 690-696